FDA Inspection
Qilu Antibiotics Pharmaceutical Co. , Ltd.Qilu Antibiotics Pharmaceutical Co. , Ltd. – FDA Inspection, May 30, 2023
Record Details
This FDA Inspection record concerns Qilu Antibiotics Pharmaceutical Co. , Ltd., with an inspection on May 30, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8aa0dc2a-11f5-467c-8d7a-3d6b0a405998
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1210065
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Qilu Antibiotics Pharmaceutical Co. , Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2026 | Not classified | Office of Inspections and Investigations | |
| August 16, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Qilu Antibiotics Pharmaceutical Co. , Ltd.
- FDA Inspection 1333262 - 2026-07-16
- FDA Inspection 1067678 - 2018-08-16
- FDA Inspection 945452 - 2015-09-22
- FDA Inspection 851836 - 2013-09-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.